Table 2.
LC–MS/MS analysis of peaks collected from RP-HPLC.
| Peak | Accession Number | Mass | Score (%) | Coverage (%) |
Description | Peptide | Mr | Start → End |
|---|---|---|---|---|---|---|---|---|
| 1 | sp|P01009|A1AT_HUMAN | 46,737 | 99 | 14.83 | Alpha-1-antitrypsin OS = Homo sapiens | IVDLVK | 685.437 | 169 → 174 |
| SVLGQLGITK | 1014.61 | 301 → 310 | ||||||
| LSITGTYDLK | 1109.59 | 291 → 300 | ||||||
| 2 | sp|P01009|A1AT_HUMAN | 46,737 | 99 | 63.40 | Alpha-1-antitrypsin OS = Homo sapiens | SPLF(OxM)GK | 794.399 | 381 → 387 |
| KLSSWVLL(OxM)K | 1219.7 | 234 → 243 | ||||||
| FNKPFVFL(OxM)IEQNTK | 1870.965 | 366 → 380 | ||||||
| GTEAAGA(OxM)FLEAIP(OxM)SIPPEVK | 2290.122 | 344 → 365 | ||||||
| 3 | sp|P01009|A1AT_HUMAN | 46,737 | 30 | 7.18 | Alpha-1-antitrypsin OS = Homo sapiens | VPM(OxM)K | 620.302 | 218 → 222 |
| 4 | sp|P01009|A1AT_HUMAN | 46,737 | 99 | 15.55 | Alpha-1-antitrypsin OS = Homo sapiens | LG(OxM)FNIQ(OxH)CK | 1221.56 | 224 → 233 |
| GTEAAGAMFLEAIP(OxM)SIPPEVK | 2274.12 | 344 → 365 | ||||||
| SPLF(OxM)GK | 794.399 | 381 → 387 | ||||||
| 5 | sp|P01009|A1AT_HUMAN | 46,737 | 99 | 64.11 | Alpha-1-antitrypsin OS = Homo sapiens | VP(OxM)(OxM)KR | 792.398 | 218 → 223 |
| GTEAAGA(OxM)FLEAIP(OxM)SIPPEVK | 2290.122 | 344 → 365 | ||||||
| 6 | sp|P01009|A1AT_HUMAN | 46,737 | 99 | 23.44 | Alpha-1-antitrypsin OS = Homo sapiens | LG(OxM)FNIQ(OxH)CKK | 1349.65 | 224 → 234 |
| KLSSWVLL(OxM)K | 1219.7 | 234 → 243 | ||||||
| GTEAAGA(OxM)FLEAIP(OxM)SIPPEVK | 2290.122 | 344 → 365 |